Acta Poloniae Pharmaceutica : Impact Factor & More
eISSN: 2353-5288pISSN: 0001-6837
Share this on:
Key Metrics
CiteScore 
0.6
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Acta Poloniae Pharmaceutica Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | POLSKIE TOWARZYSTWO FARMACEUTYCZNE |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Acta Poloniae Pharmaceutica ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Poloniae Pharmaceutica
Assessment of Potential Drug-Drug Interactions Among Patients With Ovarian Cancer Receiving Olaparib
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Strengthening Academia-Industry Collaboration to Advance Pharmaceutical and Biotechnological Innovation – a Call for Papers
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Potentially Inappropriate Prescribing Among Older Adults in Slovakia: A Population-Based Study of Pre-Pandemic Trends
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Evaluation of Medical Practice Allegation Cases Within the Scope of Pharmacy Services and Applications
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Design, Synthesis, and Evaluation of Baicalein–Thiazole–Piperazine Hybrid As Inhibitor of NF-κB Activation for Hepatobiliary Inflammation Treatment
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Assessment of Potential Drug-Drug Interactions Among Patients With Ovarian Cancer Receiving Olaparib
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Strengthening Academia-Industry Collaboration to Advance Pharmaceutical and Biotechnological Innovation – a Call for Papers
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Potentially Inappropriate Prescribing Among Older Adults in Slovakia: A Population-Based Study of Pre-Pandemic Trends
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Evaluation of Medical Practice Allegation Cases Within the Scope of Pharmacy Services and Applications
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Design, Synthesis, and Evaluation of Baicalein–Thiazole–Piperazine Hybrid As Inhibitor of NF-κB Activation for Hepatobiliary Inflammation Treatment
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
Neuroprotective Evaluation of N-Benzyl-2-[4-(Aryl)-1H-1,2, 3-Triazol-1-Yl]ethan-1-Imine Oxides
- 3 Mar 2026
- Acta Poloniae Pharmaceutica - Drug Research
FAQs on Acta Poloniae Pharmaceutica
How long has Acta Poloniae Pharmaceutica been actively publishing? 
What is the publishing frequency of Acta Poloniae Pharmaceutica?
How many articles did Acta Poloniae Pharmaceutica publish last year?
What is the eISSN & pISSN for Acta Poloniae Pharmaceutica?
What is Citescore for Acta Poloniae Pharmaceutica?
What is SNIP score for Acta Poloniae Pharmaceutica?
What is the SJR for Acta Poloniae Pharmaceutica?
Who is the publisher of Acta Poloniae Pharmaceutica?
